efficacy of imod in the treatment of oral lichen planus—efficacy of imod in oral lichen planusimod的功效治疗口腔苔藓planus-efficacy imod的口腔扁平苔癣.pdfVIP

下载本文档

1
0
约3.59万字
约 5页
2017-08-28 发布于上海
举报
版权申诉

efficacy of imod in the treatment of oral lichen planus—efficacy of imod in oral lichen planusimod的功效治疗口腔苔藓planus-efficacy imod的口腔扁平苔癣.pdf

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

efficacy of imod in the treatment of oral lichen planus—efficacy of imod in oral lichen planusimod的功效治疗口腔苔藓planus-efficacy imod的口腔扁平苔癣

Open Journal of Stomatology, 2011, 1, 13-17 OJST doi:10.4236/ojst 12003 Published Online June 2011 (http://www.SciRP.org/journal/OJST/). Efficacy of IMOD in the treatment of oral lichen planus —Efficacy of IMOD in oral lichen planus 1 2 3 1 Farzaneh Agha-Hosseini , Iraj Mirzaii-Dizgah , Mohammad Abdollahi , Neda Akbari-Gillani 1Department of Oral Medicine/Dental Research Center, Dentistry School, Tehran University of Medical Sciences, Tehran, Iran; 2Department of Physiology, School of Medicine, AJA University of Medical Sciences, Tehran, Iran; 3Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran. E-mail: aghahose@sina.tums.ac.ir; emirzaii@razi.tums.ac.ir; mohammad@tums.ac.ir Received 17 March 2011; revised 26 April 2011, accepted 13 May 2011. ABSTRACT undergo spontaneous remission, and are potentially pre- malignant. World Health Organization has categorized Objectives: Oral lichen planus (OLP) is a chronic, OLP as a pre-cancerous condition, which is “a general immunologically mediated, mucocutaneous disorder. state associated with a significant increased risk of can- A wide range of topical and systemic therapies have cer”. The pathogenesis of OLP is unclear. It was shown been used in the treatment of OLP. The efficacy of